MedTrace Logo

Observational Study to Assess Migraine Prediction Tool

NCT05523310 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-11-22

No results posted yet for this study

Summary

This is a prospective, observational study. The participant will be required to approve his/her participation in the study by completing the electronic consent form. Data collected within the first eight weeks (weeks 1-8) will be used to develop the prediction models (either personal or population/group models). The developed algorithm will be freezer and tested against the data collected during weeks 1-8 of a different cohort population

Conditions

Interventions

OTHER

Daily questionnaire

All patients will be asked to complete a daily questionnaire regarding their migraine, medications, and prodromal symptoms during that day

Sponsors & Collaborators

  • Theranica

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2030-01-01
Primary Completion
2030-10-01
Completion
2030-11-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05523310 on ClinicalTrials.gov